GlobeNewswire 27.05 BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
GlobeNewswire 13.05 Immatics Announces First Quarter 2025 Financial Results and Business Update
GlobeNewswire 12.05 Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 08.05 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05.05 BioNTech Announces First Quarter 2025 Financial Results and Corporate Update
GlobeNewswire 05.05 BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer
GlobeNewswire 02.05 Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administrat...
GlobeNewswire 24.04 BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Pr...
GlobeNewswire 22.04 BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
GlobeNewswire 15.04 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
GlobeNewswire 08.04 Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
GlobeNewswire 24.03 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Busine...
GlobeNewswire 22.03 Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
GlobeNewswire 10.03 Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
GlobeNewswire 10.03 BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
GlobeNewswire 24.02 BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March...
GlobeNewswire 12.02 Genmab Publishes 2024 Annual Report
GlobeNewswire 03.02 BioNTech Completes Acquisition of Biotheus
GlobeNewswire 30.08.2024 HOOKIPA Pharma Announces Board of Directors Changes
GlobeNewswire 22.08.2024 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 19.08.2024 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 16.08.2024 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 13.08.2024 Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08.08.2024 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08.08.2024 Genmab Updates 2024 Financial Guidance